Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 9/20 | 0.53 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4304325 | 1.00 | GNAI3 (0.53) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL4308322 | 1.00 | GNAI3 (0.53) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL4308311 | 1.00 | GNAI3 (0.53) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL4300859 | 0.85 | GNAI3 (0.47) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL4304323 | 0.83 | MEN1 (0.55) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL4308949 | 0.81 | CHRM1 (0.49) | GNAI3GNAI1MAPTCHRM1 | |
| SCHEMBL4307522 | 0.81 | CHRM1 (0.49) | GNAI3GNAI1MAPTCHRM1 | |
| SCHEMBL8972813 | 0.78 | L3MBTL1 (0.80) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL4450061 | 0.78 | L3MBTL1 (0.80) | GNAI3GNAI1L3MBTL1GNAO1MEN1 | |
| SCHEMBL8972823 | 0.78 | L3MBTL1 (0.80) | GNAI3GNAI1L3MBTL1GNAO1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2054398-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | Korea Research Institute of Bioscience and Biotechnology (KR) | 2009-05-06 | — | — | EP | claimed |
| WO-2008018778-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2008-02-14 | — | — | WO | claimed |
| EP-2054398-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | Korea Research Institute of Bioscience and Biotechnology (KR) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008018778-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2008-02-14 | — | — | WO | disclosed |